F992 TFA
Based on 1 Customer Validation
F992 TFA is an antidiuretic peptide and vasopressin (antidiuretic hormone) analogue.
For research use only. We do not sell to patients.
- Purity : 98.19%
- Formula: C47H66F3N13O13S2
- Molecular Weight:1028.21 (free base)
-
Storage:
Sealed storage, away from moisture and light.
Powder -80°C, 2 years , -20°C, 1 year* In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture and light)
To place orders, for customer services and technical support, please contact: MedChemExpress USA
Tel: 609-228-6898 E-mail: [email protected] [email protected]
-
Biological Activity
-
Chemical Information
- Protocols
- Purity & Documentation
- References
-
Help & FAQs
All Vasopressin Receptor Isoforms
More
Biological Activity
Description
Chemical Information
-
Appearance Solid
-
Molecular Weight 1028.21 (free base)
-
Formula C47H66F3N13O13S2
-
Color White to off-white
-
Sequence
Butanoic acid-{D-Phe}-{Thi}-{α-Me-Abu}-Asn-Cys-{Hyp}-{D-Arg}-Gly-NH2 (Carba sulfide bridge:butanoic acid-1 to Cys-6)
-
Sequence Shortening
Butanoic acid-{D-Phe}-{Thi}-{α-Me-Abu}-NC-{Hyp}-{D-Arg}-G-NH2 (Carba sulfide bridge:butanoic acid-1 to Cys-6)
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Sealed storage, away from moisture and light
Powder -80°C 2 years -20°C 1 year * In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture and light)
Protocols
-
Research Protocol for Endocrine Diseases
Endocrine diseases often arise from disrupted hormone production, hormone signaling, or target-tissue responsiveness; for diabetes-focused endocrine disease models, insulin signaling regulates glucose uptake, hepatic glucose output, lipid metabolism, and β-cell compensation. Type 2 diabetes develops through interacting defects in insulin resistance, β-cell dysfunction, adipose inflammation, hepatic glucose overproduction, altered incretin signaling, and ectopic lipid metabolism. A major unresolved question is whether endocrine dysfunction is driven primarily by target-tissue insulin resistance, intrinsic β-cell failure, immune/inflammatory stress, or combined multi-organ failure that differs by disease stage.
Purity & Documentation
-
Data Sheet (271 KB)
-
SDS (252 KB)
- English - EN (252 KB)
- Français - FR (252 KB)
- Deutsch - DE (252 KB)
- Norwegian - NO (252 KB)
- Español - ES (252 KB)
- Swedish - SV (252 KB)
- Italian - IT (252 KB)
- Korean - KR (252 KB)
- Portuguese - PT (252 KB)
-
Handling Instructions (2659 KB)
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
F992 TFA Related Classifications
HY-P0041A Related Classifications
Powered by Bioz